Equity · Healthcare
VCEL
NASDAQVericel (VCEL)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for VCEL to draw a line in its place.
- Market cap
- 2.4B USD
- P/E (TTM)
- 72.3
- Revenue, year to Dec 2025
- 276.3M USD
- EPS, diluted, year to Dec 2025
- 0.32 USD
- 52-week range
- 29.36 USD – 48.31 USD
- Avg volume
- 125.6K
as of Jul 17, 2026
Have Vericel (VCEL) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Vericel insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 6 Nov 2025, show no open-market purchase.
Form 4, 90 days to 9 Nov 2026, newest reported trade 5 Nov 2026
Buys 0Sells 5Net sold $1.44MOther filings 5
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Nov 2026 | Flynn Sean C.Chief Legal Officer | Sell | 15,000 | 779K USD |
| 05 Nov 2026 | SIEGAL JONATHANPrincipal Accounting Officer | Sell | 1,500 | 79K USD |
| 05 Nov 2026 | ZERBE ROBERT L MDDirector | Sell | 3,000 | 157K USD |
| 04 Nov 2026 | ZERBE ROBERT L MDDirector | Sell | 2,500 | 114K USD |
| 12 Aug 2026 | MCLAUGHLIN KEVIN FDirector | Sell | 7,000 | 312K USD |
| Sold | 5 open-market sales | 29,000 | $1.44M |
5 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Nov 2026 | Flynn Sean C.Chief Legal Officer | Option exercise | 15,000 | 244K USD |
| 05 Nov 2026 | SIEGAL JONATHANPrincipal Accounting Officer | Option exercise | 1,500 | 52K USD |
| 05 Nov 2026 | ZERBE ROBERT L MDDirector | Option exercise | 3,000 | 39K USD |
| 04 Nov 2026 | ZERBE ROBERT L MDDirector | Option exercise | 2,500 | 33K USD |
| 12 Aug 2026 | MCLAUGHLIN KEVIN FDirector | Option exercise | 7,000 | 91K USD |
Which funds hold Vericel (VCEL)?
0 of the 45 institutional funds we track reported a Vericel position for the quarter ended 30 Sep 2026; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Exited |
What has been filed or recorded for Vericel (VCEL)?
The filings we hold for Vericel, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 09 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 301 shares | 12K USD notional · 0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 20 shares | 821 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.27 USD | Revenue $85M |
| 30 Sep 2026 | Financials | Total assets | 517.1M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 384.2M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.04 USD | Revenue $77M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.12 USD | Revenue $68M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.32 USD | Revenue $276M |
| 31 Dec 2025 | Financials | Revenue | 276.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 16.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.32 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.10 USD | Revenue $68M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.01 USD | Revenue $63M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.23 USD | Revenue $53M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.20 USD | Revenue $237M |
Vericel (VCEL): frequently asked questions
What is Vericel’s market cap?
Vericel is worth 2.4B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Vericel’s P/E ratio?
Vericel has a price-to-earnings ratio of 72.3, as of 17 Jul 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Vericel’s revenue?
Vericel reported revenue of 276.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Vericel insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Vericel insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 6 Nov 2025, show no open-market purchase. A further 5 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Vericel?
0 of the 45 funds we track reported a Vericel position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
When did Vericel last report earnings?
Vericel last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.27 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings